 |
JOURNAL TOOLS |
| Opzioni di pubblicazione |
| eTOC |
| Per abbonarsi |
| Sottometti un articolo |
| Segnala alla tua biblioteca |
ARTICLE TOOLS |
| Publication history |
| Estratti |
| Permessi |
| Per citare questo articolo |
| Share |
I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
REVIEW DIFFICULT CHALLENGES IN VASCULAR MEDICINE
Minerva Medica 2021 December;112(6):740-5
DOI: 10.23736/S0026-4806.21.07474-7
Copyright © 2021 EDIZIONI MINERVA MEDICA
lingua: Inglese
Treatment of retinal vein thrombosis: what about anticoagulants?
Omar M. RASLAN 1, 2, Alejandro LAZO-LANGNER 1, 3 ✉
1 Division of Hematology, Department of Medicine, Western University, London, ON, Canada; 2 Division of Hematology, Department of Medicine, College of Medicine, Jeddah University, Jeddah, Saudi Arabia; 3 Department of Epidemiology and Biostatistics Western University, London, ON, Canada
Retinal vein occlusion is an important cause of vision loss. The current treatment options are mainly directed to the prevention of neovascular complications and few studies have addressed to potential use of anticoagulant agents and other interventions targeting the coagulation system. Herein we review the general aspects of this condition focusing on the potential benefits of anticoagulant treatment.
KEY WORDS: Retinal vein occlusion; Anticoagulants; Therapeutics